ALEXANDRIA CRUMPTON: Open Payments
NPI 1710403779 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 57 payments from 13 companies in 2025. Trend: 2023 $1,449 · 2024 $1,901 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $305 |
| Novo Nordisk Inc | 8 | $173 |
| ABBVIE INC. | 9 | $168 |
| Lilly USA, LLC | 7 | $143 |
| Amgen Inc. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Dynavax Technologies Corporation | 3 | $67 |
| Exact Sciences Corporation | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
Products named: AIRSUPRA, Wegovy, QULIPTA, TRELEGY ELLIPTA, FARXIGA, UBRELVY, TRINTELLIX, Heplisav-B.
Industry payments across FL — which companies pay providers there.
